| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |